3 Followers SGX:40V - Singapore-eDev (SGD 0.039) SINGAPORE EDEVELOPMENT LTD
Sector: Finance, Industry: Real Estate Development

Add to WatchList


Singapore shares advance after Nasdaq ends at record; STI up 0.4% at Thursday's open

9 Jan 2020 - The Business Times
SINGAPORE shares opened higher on Thursday tracking Wall Street stocks overnight, after US President Donald Trump seemed to tone down his rhetoric against Iran. The benchmark Straits Times Index gained 0.4 per cent, or 12.83 points to 3,258.72 as at 9.01am. Gainers outnumbered losers 89 to 17, after ...
sgx:c38u sgx:pu6d sgx:d05 sgx:tq5 sgx:o39 sgx:u11 sgx:575 klse:0080 sgx:so7 sgx:40v sgx:f13 sgx:bs6 hkex:5 sgx:5we sgx:c31

Stocks to watch: OCBC, Frasers Property, Fu Yu, Singapore eDevelopment

9 Jan 2020 - The Business Times
THE following companies saw new developments that may affect trading of their securities on Thursday: OCBC Bank: The lender has priced A$150 million (S$139.5 million) of senior floating-rate notes due 2022 under its US$30 billion global medium term note programme. OCBC also appointed former HSBC Greater ...
sgx:pu6d sgx:40v sgx:tq5 sgx:f13 hkex:5 sgx:o39 sgx:s68

Bumitama Agri exec chairman acquires more of its shares

23 Dec 2019 - The Business Times
FOR the five trading sessions spanning Dec 13 to Dec 19, the Straits Times Index (STI) gained 0.4 per cent with the Nikkei 225 Index, Hang Seng Index and S&P/ASX 200 Index averaging a 2.1 per cent return. This has brought the STI's 2019 total return through to Dec 19, to 8.9 per cent. Share buybacks ...
sgx:40w sgx:40v usx:dss sgx:bn4 sgx:o39 sgx:s68 klse:0080 sgx:e3b klse:5165 sgx:43p sgx:p8z sgx:k71u

Global BioLife to Present 3F Antimicrobial Fragrance at 2020 ASM Biothreats

15 Nov 2019 - ACN Newswire
Global BioLife Inc, the U.S. subsidiary of Singapore eDevelopment Ltd (SeD), will present its 3F Antimicrobial Fragrance as a new method to prevent and treat Tuberculosis at the ASM Biothreats Conference, 28 to 30 January, 2020 in Arlington, Virginia. ASM Biothreats is a one-of-a-kind program that explores ...
sgx:40v sgx:s68

Global BioLife Inc. to present Functional Fragrance Formula at the American Society for Microbiology's Biothreats Conference as a New Method to Prevent and Treat Tuberculosis

29 Oct 2019 - ACN Newswire
SGX-listed Singapore eDevelopment Limited ("SeD", SGX:40V) wishes to announce that its biomedical subsidiary incorporated in Nevada, Global BioLife Inc. ("Global BioLife") will be presenting its research on its Functional Fragrance Formula ("3F") against tuberculosis at the 2020 American Society for ...
sgx:40v sgx:s68

Global BioLife Inc.'s Naturally Modified Sugar Laetose(TM) Unveiled at Harvard Global Health Summit

24 Jul 2019 - ACN Newswire
SGX-listed Singapore eDevelopment Ltd ("SeD", SGX:40V) is pleased to announce the results of clinical trials conducted on Laetose(TM), a low-glycemic, naturally modified sugar, developed by its U.S. biomedical subsidiary Global BioLife Inc. ("Global BioLife").Clinical trial results show that Laetose ...
klse:4863 sgx:40v sgx:s68

Global BioLife's new mosquito repellent formula performs well against mosquitos in independent testing

12 Jun 2019 - ACN Newswire
Singapore Exchange-listed Singapore eDevelopment Limited (Stock Code 40V) ("SeD") wishes to announce today that its U.S. biomedical subsidiary, Global BioLife Inc. ("Global BioLife"), has independently tested a new mosquito repellent formula which performs well against mosquitos for six (6) to eight ...
sgx:40v sgx:s68

Singapore eDevelopment (SGX:40V) Subsidiary, Global BioLife's 3F Antimicrobial Fragrance Shows Efficacy against Tuberculosis

28 Jan 2019 - ACN Newswire
Singapore Exchange-listed Singapore eDevelopment Limited (Stock Code 40V) ("SeD") wishes to announce today that its U.S. biomedical subsidiary, Global BioLife Inc. ("Global BioLife") has a product known as 3F Antimicrobial Fragrance which shows efficacy against tuberculosis.Tuberculosis is the leading ...
sgx:40v

Singapore eDevelopment (SGX:40V) Subsidiary, Global BioLife, Proudly Announces Presentation of Parkinson's Research at Neuroscience 2018

7 Nov 2018 - ACN Newswire
Singapore Exchange-listed Singapore eDevelopment Limited (Stock Code 40V) ("SeD"), through its subsidiary, Global BioLife Inc. ("Global BioLife") is pleased to announce that research of their promising drug platform, Linebacker, will be presented at Neuroscience 2018, the Annual Meeting for the International ...
sgx:40v sgx:s68

Singapore eDevelopment Announces Corporate and Business Update

18 Jun 2018 - ACN Newswire
The Board of Directors of Singapore eDevelopment Limited ('SeD'; SGX 40V) wishes to provide shareholders an update on the Group's operations. 1 - Review of Core Businesses SGX Catalist-listed SeD (Stock Code: 40V) has strategically positioned itself as an investment holding company and embarked into ...
sgx:40v